Charlesbank-backed Tecomet and Nordic Capital-backed Orchid Orthopedic Solutions have merged, creating a combined manufacturing partner serving both medtech and aerospace and defense customers. The new company will operate under the Tecomet name, with Andreas Weller retaining as CEO.

Tecomet, based in Woburn, Massachusetts, runs 14 manufacturing locations across five countries. Orchid, headquartered in Mason, Michigan, operates 10 facilities across the US, UK, and Switzerland and specializes in implants, instruments, and technologies for joint reconstruction, hips, knees, spine, trauma, extremities, and dental.

The merger unites two PE-backed manufacturers with a combined footprint across dozens of facilities and multiple countries. Deal terms and financing details were not disclosed, but the combined entity now positions itself as a broader manufacturing platform for both medical technology and aerospace and defense sectors.